title: New regulatory paradigms for innovative drugs to treat pediatric diseases.
authors.affiliation: Faculty of Arts and Sciences, Harvard University, Cambridge, Massachusetts2The Blackstone Group, London, England.
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Hwang
authors.affiliation: Division of Emergency Medicine, Boston Children's Hospital, Boston, Massachusetts4Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.
authors.forename: Florence T
authors.initials: FT
authors.lastname: Bourgeois
mesh_terms: D002648:Child; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D055808:Drug Discovery / Q000331:legislation & jurisprudence*; D006801:Humans; D035583:Rare Diseases / Q000188:drug therapy*; D035703:Therapies, Investigational
references.citation: JAMA Pediatr. 2013 Oct;167(10):886-7
references.pmid: 23938865
references.citation: Pediatrics. 2014 May;133(5):e1197-202
references.pmid: 24733871
references.citation: Clin Pharmacol Ther. 2009 Jun;85(6):573-5
references.pmid: 19451908
references.citation: Pediatrics. 2012 Mar;129(3):516-21
references.pmid: 22371464
references.citation: Rare Dis. 2013 Jan 28;1:e23579
references.pmid: 25002987
references.citation: Sci Transl Med. 2011 Jan 19;3(66):66cm1
references.pmid: 21248312